BioSpace News Archive

With 2025 set to be a pivotal year for TA teams, we are excited to announce the return of the 7th LEAP TA: Life Sciences to Boston this September!

LEAP HR: Emerging Biopharma is your only opportunity to uncover how your peers are recognizing and retaining their high-performer R&D employees with no budget, how they’re repositioning career development amongst mass layoffs, and how they are re-imagining culture and employee engagement to keep their scientific workforce motivated.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.

Register and find information for upcoming events from BioSpace and partners.
Interested in publishing your upcoming event on BioSpace? Submit events here.
Interested in putting on your own event? Talk to us.

Leslie Zhen Liang is an award-winning investigative health and science journalist with a decade of experience covering medicine and health in China.

Vertex reported healthy revenue in its second quarter earnings report, though news of VX-993’s mid-stage trial results and lack of alignment with the FDA regarding an expanded label for Journavx tempered analyst reactions, sending the stock down 13%.

BMN 390 fell short of an immunogenicity threshold that BioMarin was looking for to support its further development. Employees working on the program have been redeployed within the company.

Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other pharmaceutical companies to lower drug prices or face consequences.